oncology Flashcards
breast cancer screening [age/freq]
45-54/annual mammogram
55+/every 2 years, or annually
cervical cancer screening [age/freq]
26-65/ cervical cell analysis:
* PAP Q 3 years
* HPV DNA test Q 5 years
* or both Q5 years
colorectal cancer screening [age/freq]
45+
Stool tests: FIT/FOBT yearly, MT-sDNA Q3Y
Visual exam: colon/rectal colonoscopy Q10Y and PRN confirm dx, flexible sigmoidoscopy Q5Y
lung cancer screening [age/freq]
Annual low dose CT scan of chest if 2 criteria met:
1. 20+ year smoking hx
2. Still smoking/quit within last 15 years
prostate cancer screening
individualized decision
PSA blood test
DRE (digital rectal exam optional)
CAUTION warning sign
Chance in bowel/bladder habits
A sore that does not heal (Abcess)
Unusual bleeding or discharge
Thickening or lump (breast/elsewhere)
Indigestion or difficulty swallowing
Obvious change in wart or mole (ABCDE)
Nagging cough or hoarseness
Cancer # staging system
1 = early stage
5 = advanced disease
TNM staging system
T = primary tumor size/location
N = lymph node involvement
M = mets evidence
Evaluating cancer
Biopsy
Imaging
Biomarker
others (genetics, CBC,CMP, H&P)
Carcinoma
epithelial cells that line internal/external body surfaces
Leukemia
Bone marrow - affects leukocytes
Lymphoma
Begins in lymphatic system cells
Multiple myeloma
arise from PLASMA CELLS of bone marrow
Sarcoma
connective tissue or supportive tissue (bone, cartilage, muscle)
neoadjuvant therapy
before surgery to shrink tumor
adjuvant therapy
after primary tx, eradicate residuals + prevent reoccurrence
M phase chemo drugs
Taxanes
Vinca alkaloids
G2 phase chemo drugs
Etoposide
Bleomycin
G1 phase chemo drugs
pegaspargase
S phase chemo drugs
“AT the s phase, the DNA replicATes”
Antimetabolites (MTX, 5-FU)
Topoisomerase 1 inhibitors (irinotecan, topotecan)
non-cell cycle specific chemo drugs
“All Awesome Pharmacists”
Alkylating agents
Anthracyclines
Platinum compounds
Mosteller equation
BSA = SQRT (cm x kg /3600)
Du Bois equation
BSA = 0.007184 x cm^0.725 x kg^0.425
Calvert formula
carboplatin dosing
need AUC (range 2-8 mg/ml*min)
GFR max 125
CrCl ok if GFR not available to estimate GFR
TOTAL carbo dose (mg) = target AUC x (GFR + 25)
list the alkylating agents
non-specific
Platinum based
nonspecific
Anthracyclines
nonspecific
Doxorubicin, “-rubicin”
Mitoxantrone (blue)
LIFETIME MAX - cardiotoxicity
MOA: MULT - intercalate DNA, inhibit TOPO2, create ROS damage cells
Total lifetime cummulative dose for anthracyclines
450-550 mg/m^2